Search Within

Azeez Farooki

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Biostatistics Service (11)
  2. Department of Medicine (11)
  3. Division of Subspecialty Medicine (11)
  4. Endocrinology (11)
  5. Epidemiology and Biostatistics (11)
  6. Survivorship Research (11)

More Groups

People
  1. Clifford Hudis (4)
  2. Monica Fornier (4)
  3. Sujata Patil (4)
  4. Martin Fleisher (3)
  5. Michael Morris (3)
  6. Aaron Mitchell (2)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2020 (1)
  4. 2017 (1)
  5. 2015 (1)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. EJC Supplements (1)
  5. Journal of Bone Oncology (1)
  6. Journal of Oral and Maxillofacial Surgery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (2)
  3. Elsevier Ltd (1)
  4. Nature Publishing Group (1)
  5. Pergamon-Elsevier Science Ltd (1)
  6. W.B. Saunders Co-Elsevier Inc. (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Bone remineralization of lytic lesions in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib, lenalidomide, dexamethasone +/- daratumumab induction regimen
    Meeting Abstract

    Meseha, M.; Abusamra, M.; Farooki, A.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Shah, U.; Lu, S.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Use of bone modifying agents for metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Farooki, A.; Panageas, K.; Bach, P. B.; Lipitz-Snyderman, A.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma
    Journal Article

    McPherson, V.; Reardon, B.; Bhayankara, A.; Scott, S. N.; Boyd, M. E.; Whiting, K.; Garcia-Grossman, I. R.; Regazzi, A. M.; McCoy, A. S.; Kim, P. H.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score
    Journal Article

    Mariotti, V.; Page, D. B.; Davydov, O.; Hans, D.; Hudis, C. A.; Patil, S.; Kunte, S.; Girotra, M.; Farooki, A.; Fornier, M. N.
    Journal of Bone Oncology (2017)

    Fulltext@MSK | Save
  • A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI)
    Meeting Abstract

    Page, D. B.; Mariotti, V.; Davydov, O.; Patil, S.; Hans, D.; Hudis, C. A.; Farooki, A.; Fornier, M. N.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Risk assessment for severe hypocalcemia requiring hospitalization with denosumab
    Meeting Abstract

    Autio, K. A.; Farooki, A.; Glezerman, I.; Chan, A.; Barr, H. C.; Seyboth, B. M.; Schneider, C. W.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors
    Journal Article

    Berman, E.; Girotra, M.; Cheng, C.; Chanel, S.; Maki, R.; Shelat, M.; Strauss, H. W.; Fleisher, M.; Heller, G.; Farooki, A.
    Leukemia Research (2013)

    Fulltext@MSK | Save
  • Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving Bisphosphonates for bone metastases
    Journal Article

    Morris, P. G.; Fazio, M.; Farooki, A.; Estilo, C.; Mallam, D.; Conlin, A.; Patil, S.; Fleisher, M.; Cremers, S.; Huryn, J.; more...
    Journal of Oral and Maxillofacial Surgery (2012)

    Fulltext@MSK | Save
  • Diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
    Meeting Abstract

    Feilchenfeldt, J. W.; Capanu, M.; Farooki, A.; Sully, D.; Miron, B.; Power, D. G.; Jhawer, M.; Ilson, D. H.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save